Litfulo 50 mg, Hartkapseln

7680696950013 CH-69695 Kapseln

Associated product:

LITFULO caps 50 mg 30 pce
Litfulo 50 mg, Hartkapseln
Litfulo 50 mg, Hartkapseln
Litfulo 50 mg, Hartkapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2025
Patient information leaflet
Français
01/05/2025
Patient information leaflet
Italien
01/05/2025
Summary of Product Characteristics
Allemand
01/05/2025
Summary of Product Characteristics
Français
01/05/2025
Summary of Product Characteristics
Italien
01/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
21.269 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69695
Drug name
Litfulo, Hartkapseln
Galenic form
KAHA
ATC Code
L04AF08
Authorization status
Z
Dispensing category
B
First authorization
03/02/2025
Authorization expiration date
02/02/2030
IT Number
07.15.0.
Domain
Human medicine
Field of application
Behandlung von schwerer Alopecia areata (≥50 % der Kopfhaut betroffen) bei Erwachsenen bis maximal 65 Jahre und Jugendlichen ab einem Alter von 12 Jahren, die für eine systemische Therapie in Frage kommen

Package details

Description (FR)
LITFULO caps 50 mg 30 pce
Description (DE)
LITFULO Kaps 50 mg 30 Stk
Market launch
03/02/2025
Narcotic (BTM)
No